Page last updated: 2024-10-22

albuterol and Active Hyperemia

albuterol has been researched along with Active Hyperemia in 2 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ibrahim, NNIN1
Rasool, AHG1
Holland, MG1

Reviews

1 review available for albuterol and Active Hyperemia

ArticleYear
Autonomic drugs in ophthalmology: some problems and promises. Section III: Sympathomimetic drugs.
    Annals of ophthalmology, 1974, Volume: 6, Issue:9

    Topics: Adrenergic beta-Agonists; Albuterol; Animals; Aqueous Humor; Cats; Cornea; Depression, Chemical; Epi

1974

Other Studies

1 other study available for albuterol and Active Hyperemia

ArticleYear
Assessment of macrovascular endothelial function using pulse wave analysis and its association with microvascular reactivity in healthy subjects.
    Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2017, Volume: 23, Issue:3

    Topics: Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Cross-Sectional Studies; Endothelium, Vascula

2017